Cargando…
Enhanced safety surveillance of STAMARIL® yellow fever vaccine provided under the expanded access investigational new drug program in the USA
BACKGROUND: YF-VAX® (Sanofi, Swiftwater, PA), a live, attenuated vaccine based on the yellow fever (YF) substrain 17D-204, is the only YF vaccine licensed in the USA. Manufacturing disruption of YF-VAX and anticipated depletion of the US supply by mid-2017 led to the importation of another YF vaccin...
Autores principales: | Rojas, Andrey, Hachey, Wayne, Kaur, Gurpreet, Korejwo, Joanna, Muhammad, Riyadh |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Oxford University Press
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10658653/ https://www.ncbi.nlm.nih.gov/pubmed/37000007 http://dx.doi.org/10.1093/jtm/taad037 |
Ejemplares similares
-
Update: Temporary Total Depletion of U.S. Licensed Yellow Fever Vaccine for Civilian Travelers Addressed by Investigational New Drug Use of Imported Stamaril Vaccine
por: Gershman, Mark D., et al.
Publicado: (2017) -
Sentinel surveillance for yellow fever in Kenya, 1993 to 1995.
por: Sanders, E J, et al.
Publicado: (1996) -
Timeliness of Yellow Fever Surveillance, Central African Republic
por: Rachas, Antoine, et al.
Publicado: (2014) -
Yellow fever surveillance suggests zoonotic and anthroponotic emergent potential
por: Aliaga-Samanez, Alisa, et al.
Publicado: (2022) -
Yellow Fever
Publicado: (1898)